{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T21:36:33Z","timestamp":1776375393427,"version":"3.51.2"},"reference-count":330,"publisher":"Elsevier","isbn-type":[{"value":"9780443295645","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.apcsb.2024.10.001","type":"book-chapter","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:16:56Z","timestamp":1731723416000},"page":"191-269","source":"Crossref","is-referenced-by-count":4,"title":["Leveraging nuclear receptor mediated transcriptional signaling for drug discovery: Historical insights and current advances"],"prefix":"10.1016","author":[{"given":"Riya","family":"Ben Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surbhi Kumari","family":"Barnwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arabi Mohammed","family":"Saleh M. A.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dileep","family":"Francis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2024.10.001_bib1","first-page":"325","article-title":"Repurposing simeprevir, calpain inhibitor IV and a cathepsin F inhibitor against SARS-CoV-2 and insights into their interactions with Mpro","volume":"40","author":"Abhithaj","year":"2022"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10741-016-9553-8","article-title":"Tissue thyroid hormones and thyronamines","volume":"21","author":"Accorroni","year":"2016","journal-title":"Heart Failure Reviews"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.10.001_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.xfss.2023.06.003","article-title":"Efficacy and safety of vilaprisan in women with uterine fibroids: Data from the asteroid 3 randomized controlled trial","volume":"4","author":"Al-Hendy","year":"2023","journal-title":"F&S Science"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib4","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/cells12081117","article-title":"Progesterone signaling and uterine fibroid pathogenesis; molecular mechanisms and potential therapeutics","volume":"12","author":"Ali","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1128\/MCB.17.2.934","article-title":"Role of hydrophobic amino acid clusters in the transactivation activity of the human glucocorticoid receptor","volume":"17","author":"Alml\u00f6f","year":"1997","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1677\/JOE-08-0539","article-title":"A TR\u03b2-selective agonist confers resistance to diet-induced obesity","volume":"203","author":"Amorim","year":"2009","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.4184\/asj.2016.10.4.787","article-title":"Selective estrogen receptor modulators","volume":"10","author":"An","year":"2016","journal-title":"Asian Spine Journal"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib8","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1530\/JOE-17-0708","article-title":"Thyroid hormone receptor localization in target tissues","volume":"237","author":"Anyetei-Anum","year":"2018","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib9","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.tem.2009.03.011","article-title":"Thyroid receptor: Roles in cancer","volume":"20","author":"Aranda","year":"2009","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib10","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.2001.81.3.1269","article-title":"Nuclear hormone receptors and gene expression","volume":"81","author":"Aranda","year":"2001","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib11","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/S1043-2760(97)00159-8","article-title":"Chromatin modulation of glucocorticoid and progesterone receptor activity","volume":"8","author":"Archer","year":"1997","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib12","series-title":"StatPearls","article-title":"Physiology, Thyroid Function","author":"Armstrong","year":"2024"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ajur.2018.07.003","article-title":"Current strategies for targeting the activity of androgen receptor variants","volume":"6","author":"Armstrong","year":"2019","journal-title":"Asian Journal of Urology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib14","doi-asserted-by":"crossref","first-page":"43048","DOI":"10.1074\/jbc.M506693200","article-title":"Discovery of small molecule inhibitors of the interaction of the thyroid hormone receptor with transcriptional coregulators","volume":"280","author":"Arnold","year":"2005","journal-title":"Journal of Biological Chemistry"},{"issue":"22","key":"10.1016\/bs.apcsb.2024.10.001_bib15","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1021\/jm070556y","article-title":"Inhibitors of the Interaction of Thyroid Hormone Receptor and Coactivators: Preliminary Structure\u2013Activity Relationships","volume":"50","author":"Arnold","year":"2007","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib17","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1080\/07391102.2020.1779819","article-title":"Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target","volume":"39","author":"Arun","year":"2021","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105599","article-title":"Systemic distribution of progesterone receptor subtypes in human tissues","volume":"199","author":"Asavasupreechar","year":"2020","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib19","first-page":"5214","article-title":"New insights into the functions of progesterone receptor (PR) isoforms and progesterone signaling","volume":"11","author":"Azeez","year":"2021","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2019.101443","article-title":"The role of nuclear receptors in the differentiation of oligodendrocyte precursor cells derived from fetal and adult neural stem cells","volume":"37","author":"Baldassarro","year":"2019","journal-title":"Stem Cell Research"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1210\/edrv-17-3-245","article-title":"Molecular determinants of glucocorticoid receptor function and tissue sensitivity to glucocorticoids","volume":"17","author":"Bamberger","year":"1996","journal-title":"Endocrine Reviews"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.10.001_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.contraception.2006.06.004","article-title":"Pharmacokinetics and safety of tanaproget, a nonsteroidal progesterone receptor agonist, in healthy women","volume":"74","author":"Bapst","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib23","doi-asserted-by":"crossref","unstructured":"Barakat, R., Park, C.J., P\u00e9rez, P.A., Chiu, K., & Ko, C. (2018). Female antiestrogens.","DOI":"10.1016\/B978-0-12-801238-3.64414-8"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib24","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1089\/thy.2018.0008","article-title":"Sobetirome and its amide prodrug Sob-AM2 exert thyromimetic actions in Mct8-deficient brain","volume":"28","author":"B\u00e1rez-L\u00f3pez","year":"2018","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib25","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1042\/cs0940557","article-title":"Anti-inflammatory actions of glucocorticoids: Molecular mechanisms","volume":"94","author":"Barnes","year":"1998","journal-title":"Clinical Science (London, England: 1979)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrrheum.2012.166","article-title":"The multiple facets of glucocorticoid action in rheumatoid arthritis","volume":"8","author":"Baschant","year":"2012","journal-title":"Nature Reviews. Rheumatology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib27","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1210\/me.2007-0157","article-title":"Thyroid status during skeletal development determines adult bone structure and mineralization","volume":"21","author":"Bassett","year":"2007","journal-title":"Molecular Endocrinology (Baltimore, Md.)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1677\/JME-08-0142","article-title":"The skeletal phenotypes of TRalpha and TRbeta mutant mice","volume":"42","author":"Bassett","year":"2009","journal-title":"Journal of Molecular Endocrinology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.10.001_bib29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/HYPERTENSIONAHA.114.04488","article-title":"Mineralocorticoid receptor activation and mineralocorticoid receptor antagonist treatment in cardiac and renal diseases","volume":"65","author":"Bauersachs","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib30","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/glia.22697","article-title":"A selective thyroid hormone \u03b2 receptor agonist enhances human and rodent oligodendrocyte differentiation","volume":"62","author":"Baxi","year":"2014","journal-title":"Glia"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.08.007","article-title":"Transcriptional control of skin reepithelialization","volume":"73","author":"Bellavia","year":"2014","journal-title":"Journal of Dermatological Science"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib32","first-page":"1031","article-title":"Use of statins as lipid lowering agent in hypercholesterolemia in a tertiary care\u00a0hospital:\u00a0A\u00a0descriptive\u00a0cross-sectional\u00a0study","volume":"58","author":"Bhattarai","year":"2020","journal-title":"JNMA: Journal of the Nepal Medical Association"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib33","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/rheumatology\/ker215","article-title":"Dynamic regulation of glucocorticoid signalling in health and disease","volume":"51","author":"Biddie","year":"2012","journal-title":"Rheumatology (Oxford, England)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib34","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/me.2004-0486","article-title":"Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes","volume":"19","author":"Bj\u00f6rnstr\u00f6m","year":"2005","journal-title":"Molecular Endocrinology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.10.001_bib35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1681\/ASN.V9190","article-title":"D-thyroxine reduces lipoprotein(a) serum concentration in dialysis patients","volume":"9","author":"Bommer","year":"1998","journal-title":"Journal of the American Society of Nephrology: JASN"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib36","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1172\/JCI39987","article-title":"Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance","volume":"120","author":"Bonapace","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib37","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1124\/pr.112.006833","article-title":"Nuclear receptors and their selective pharmacologic modulators","volume":"65","author":"Burris","year":"2013","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib38","doi-asserted-by":"crossref","unstructured":"Burris, T. P., Vera, I. M. S. de, Cote, I., Flaveny, C. A., Wanninayake, U. S., Chatterjee, A., \u2026 Cidlowski, J. A. (2023). International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily - Update 2023. Pharmacological Reviews. https:\/\/doi.org\/10.1124\/pharmrev.121.000436.","DOI":"10.1124\/pharmrev.121.000436"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib39","first-page":"26","article-title":"A fresh look at glucocorticoids how to use an old ally more effectively","volume":"70","author":"Buttgereit","year":"2012","journal-title":"Bulletin of the NYU Hospital for Joint Diseases"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib40","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/hep.22572","article-title":"Reduction of hepatic steatosis in rats and mice after treatment with a liver-targeted thyroid hormone receptor agonist","volume":"49","author":"Cable","year":"2009","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib41","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1101\/gad.11.24.3351","article-title":"Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK\u2009pathway","volume":"11","author":"Caelles","year":"1997","journal-title":"Genes & Development"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib42","unstructured":"Cancer statistics, 2023 - American Cancer Society Journals. Available at: https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.3322\/caac.21763 (Accessed: 03 August 2024)."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jsbmb.2003.11.012","article-title":"Skeletal muscle: A dual system to measure glucocorticoid-dependent transactivation and transrepression of gene regulation","volume":"88","author":"Carballo-Jane","year":"2004","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib44","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3816\/CBC.2005.s.008","article-title":"The history and mechanism of action of fulvestrant","volume":"6","author":"Carlson","year":"2005","journal-title":"Clinical Breast Cancer"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib45","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(17)30703-1","article-title":"Hypothyroidism","volume":"390","author":"Chaker","year":"2017","journal-title":"Lancet (London, England)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib46","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00124384","article-title":"Models for the binding of amiodarone to the thyroid hormone receptor","volume":"6","author":"Chalmers","year":"1992","journal-title":"Journal of Computer-Aided Molecular Design"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib47","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.cbpa.2008.07.001","article-title":"Nuclear receptor drug discovery","volume":"12","author":"Chen","year":"2008","journal-title":"Current Opinion in Chemical Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib48","unstructured":"Chen, Y. et al. (2022). Second generation androgen receptor antagonists and challenges in prostate cancer treatment.\u00a0Nature News. Available at: https:\/\/www.nature.com\/articles\/s41419-022-05084\u20131 (Accessed: 03 August 2024)."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1023\/A:1010052101214","article-title":"Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors","volume":"1","author":"Cheng","year":"2000","journal-title":"Reviews in Endocrine & Metabolic Disorders"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib50","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1210\/er.2009-0007","article-title":"Molecular aspects of thyroid hormone actions","volume":"31","author":"Cheng","year":"2010","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib51","series-title":"Methods in enzymology","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/bs.mie.2020.02.011","article-title":"Design of synthetic retinoids","author":"Chisholm","year":"2020"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3803\/EnM.2024.203","article-title":"Selective agonists of thyroid hormone receptor beta: Promising tools for the treatment of nonalcoholic fatty liver disease","volume":"39","author":"Cho","year":"2024","journal-title":"Endocrinology and Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib53","first-page":"pe48","article-title":"Intracellular glucocorticoid signaling: A formerly simple system turns stochastic","volume":"2005","author":"Chrousos","year":"2005","journal-title":"Science\u2019s STKE: Signal Transduction Knowledge Environment"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib54","unstructured":"Cingam, S. R., & Koshy, N. V. (2017). Acute promyelocytic leukemia."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188430","article-title":"Latest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies","volume":"1874","author":"Clarisse","year":"2020","journal-title":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib56","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tibs.2024.01.012","article-title":"Glucocorticoid receptor signaling: Intricacies and therapeutic opportunities","volume":"49","author":"Clarisse","year":"2024","journal-title":"Trends in Biochemical Sciences"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.10.001_bib57","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.ccell.2024.02.004","article-title":"Retinoic acid receptor activation reprograms senescence response and enhances anti-tumor activity of natural killer cells","volume":"42","author":"Colucci","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib58","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3727\/105221617X14968563796227","article-title":"GC-1: A thyromimetic with multiple therapeutic applications in liver disease","volume":"17","author":"Columbano","year":"2017","journal-title":"Gene Expression"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib59","series-title":"Greenspan\u2019s basic & clinical endocrinology","article-title":"Chapter 7. The thyroid gland","author":"Cooper","year":"2011"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nrm3932","article-title":"Mechanisms of retinoic acid signalling and its roles in organ and limb development","volume":"16","author":"Cunningham","year":"2015","journal-title":"Nature Reviews.\u00a0Molecular Cell Biology"},{"issue":"9","key":"10.1016\/bs.apcsb.2024.10.001_bib61","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1158\/1535-7163.MCT-18-0037","article-title":"Novel trifluoromethylated Enobosarm analogues with potent antiandrogenic activity in vitro and tissue selectivity in vivo","volume":"17","author":"Dart","year":"2018","journal-title":"Molecular Cancer Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.5500\/wjt.v11.i11.443","article-title":"Current status of glucocorticoid usage in solid organ transplantation","volume":"11","author":"Dashti-Khavidaki","year":"2021","journal-title":"World Journal of Transplantation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib63","first-page":"3","article-title":"Androgen receptor structure, function and biology: From bench to bedside","volume":"37","author":"Davey","year":"2016","journal-title":"The Clinical Biochemist Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbalip.2011.09.014","article-title":"The retinoid X receptors and their ligands","volume":"1821","author":"Dawson","year":"2012","journal-title":"Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib65","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.coph.2010.04.007","article-title":"Targeting inflammation using selective glucocorticoid receptor modulators","volume":"10","author":"De Bosscher","year":"2010","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib66","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1182\/bloodadvances.2022008806","article-title":"Targeting RARA overexpression with tamibarotene, a potent and selective RAR\u03b1 agonist, is a novel approach in AML","volume":"7","author":"De Botton","year":"2023","journal-title":"Blood Advances"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib67","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/232435","article-title":"A role for estrogen receptor phosphorylation in the resistance to tamoxifen","volume":"2011","author":"De Leeuw","year":"2011","journal-title":"International Journal of Breast Cancer"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nrd2398","article-title":"Design of selective nuclear receptor modulators: RAR and RXR as a case study","volume":"6","author":"De Lera","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.10.001_bib69","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1080\/17425255.2018.1530214","article-title":"Glucocorticoids use in kidney transplant setting","volume":"14","author":"De Lucena","year":"2018","journal-title":"Expert Opinion on Drug Metabolism & Toxicology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib70","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/jcm9041034","article-title":"Thyroid hormone diseases and osteoporosis","volume":"9","author":"Delitala","year":"2020","journal-title":"Journal of Clinical Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib71","doi-asserted-by":"crossref","first-page":"18520","DOI":"10.1016\/S0021-9258(19)81389-3","article-title":"Interaction of the Mr = 90,000 heat shock protein with the steroid-binding domain of the glucocorticoid receptor","volume":"263","author":"Denis","year":"1988","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib72","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1172\/JCI88886","article-title":"Glucocorticoid receptors: Finding the middle ground","volume":"127","author":"Desmet","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib73","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.4103\/2230-8210.83339","article-title":"Thyroid disorders and bone mineral metabolism","volume":"15","author":"Dhanwal","year":"2011","journal-title":"Indian Journal of Endocrinology and Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrg.2017.102","article-title":"Nuclear receptors in cancer\u2014Uncovering new and evolving roles through genomic analysis","volume":"19","author":"Dhiman","year":"2018","journal-title":"Nature Reviews Genetics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2014.12.003","article-title":"Retinoic acid receptors: From molecular mechanisms to cancer therapy","volume":"41","author":"Di Masi","year":"2015","journal-title":"Molecular aspects of medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib76","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1111\/jphp.13168","article-title":"The effect of eplerenone on the renin-angiotensin-aldosterone system of rats with thyroid dysfunction","volume":"71","author":"Dizaye","year":"2019","journal-title":"Journal of Pharmacy and Pharmacology"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.10.001_bib77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/106002809703100112","article-title":"Nilutamide: An antiandrogen for the treatment of prostate cancer","volume":"31","author":"Dole","year":"1997","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2018.04.040","article-title":"Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: A\u00a0review","volume":"37","author":"Donnez","year":"2018","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib79","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1002\/j.1460-2075.1991.tb07760.x","article-title":"Unregulated expression of c\u2010Jun or c\u2010Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells","volume":"10","author":"Doucas","year":"1991","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib80","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3181\/00379727-53-14219P","article-title":"Effect of pituitary adrenotropic hormone on lymphoid tissue","volume":"53","author":"Dougherty","year":"1943","journal-title":"Proceedings of the Society for Experimental Biology and Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105016","article-title":"Potential drug development and therapeutic approaches for clinical intervention in COVID-19","volume":"114","author":"Dowarah","year":"2021","journal-title":"Bioorganic Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib82","series-title":"StatPearls","article-title":"Levothyroxine","author":"Eghtedari","year":"2024"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib83","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12325-020-01555-z","article-title":"Medical therapy for fibroids: What next for ulipristal acetate?","volume":"38","author":"Ekanem","year":"2021","journal-title":"Advances in Therapy"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib84","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11883-016-0564-7","article-title":"Thyroid hormone mimetics: The past, current status and future challenges","volume":"18","author":"Elbers","year":"2016","journal-title":"Current Atherosclerosis Reports"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib85","doi-asserted-by":"crossref","first-page":"15490","DOI":"10.1073\/pnas.0702759104","article-title":"Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index","volume":"104","author":"Erion","year":"2007","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib86","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3389\/fimmu.2019.01859","article-title":"Fighting the fire: Mechanisms of inflammatory gene regulation by the glucocorticoid receptor","volume":"10","author":"Escoter-Torres","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib87","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1210\/me.2007-0174","article-title":"Structural insight into the mode of action of a direct inhibitor of coregulator binding to the thyroid hormone receptor","volume":"21","author":"Est\u00e9banez-Perpi\u00f1\u00e1","year":"2007","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000132846","article-title":"The human mineralocorticoid receptor gene (MLR) is located on chromosome 4 at q31. 2","volume":"52","author":"Fan","year":"1989","journal-title":"Cytogenetic and Genome Research"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib89","first-page":"1624","article-title":"Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review)","volume":"40","author":"Fang","year":"2017","journal-title":"International Journal of Molecular Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib90","doi-asserted-by":"crossref","first-page":"3J","DOI":"10.1016\/S0002-9149(98)00423-8","article-title":"Current and future treatment of hyperlipidemia: The role of statins","volume":"82","author":"Farnier","year":"1998","journal-title":"The American Journal of Cardiology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib91","unstructured":"Farrar, M. C., & Jacobs, T. F. (2018). Tamoxifen."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib92","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3390\/scipharm84030409","article-title":"Estrogen receptor ligands: A review (2013\u20132015)","volume":"84","author":"Farzaneh","year":"2016","journal-title":"Scientia Pharmaceutica"},{"issue":"46","key":"10.1016\/bs.apcsb.2024.10.001_bib93","doi-asserted-by":"crossref","first-page":"16363","DOI":"10.1073\/pnas.0407262101","article-title":"Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease","volume":"101","author":"Fernandez","year":"2004","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib94","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.bmc.2017.03.047","article-title":"Ester-to-amide rearrangement of ethanolamine-derived prodrugs of sobetirome with increased blood-brain barrier penetration","volume":"25","author":"Ferrara","year":"2017","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib95","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/pr.58.4.3","article-title":"International union of pharmacology. LIX. The pharmacology and classification of the nuclear receptor superfamily: Thyroid hormone receptors","volume":"58","author":"Flamant","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib96","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1016\/j.bbagen.2012.06.003","article-title":"Thyroid hormone receptors: The challenge of elucidating isotype-specific functions and cell-specific response","volume":"1830","author":"Flamant","year":"2013","journal-title":"Biochimica Et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib97","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1002\/j.1460-2075.1996.tb00664.x","article-title":"Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor beta: Evidence for tissue-specific modulation of receptor function","volume":"15","author":"Forrest","year":"1996","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib98","series-title":"Advances in protein chemistry and structural biology","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/bs.apcsb.2023.08.002","article-title":"The biofilm proteome of Staphylococcus aureus and its implications for therapeutic interventions to biofilm-associated infections","author":"Francis","year":"2024"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib99","series-title":"Drugs from nature: Targets, assay systems and leads","first-page":"43","article-title":"Trawling the genome: Drug target identification in the postgenomic era","author":"Francis","year":"2024"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.10.001_bib100","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/EBC20210020","article-title":"Nuclear receptors: From molecular mechanisms to therapeutics","volume":"65","author":"Frigo","year":"2021","journal-title":"Essays in Biochemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib101","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apcsb.2019.01.001","article-title":"Estrogen receptor signaling mechanisms","volume":"116","author":"Fuentes","year":"2019","journal-title":"Advances in Protein Chemistry and Structural Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib102","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/01.HYP.0000193502.77417.17","article-title":"Mechanisms of mineralocorticoid action","volume":"46","author":"Fuller","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib103","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2741\/1685","article-title":"Progesterone receptors: Various forms and functions in reproductive tissues","volume":"10","author":"Gadkar-Sable","year":"2005","journal-title":"Front Biosci"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib104","first-page":"120","article-title":"Long-term effect of dried thyroid on serum-lipoprotein and serum-cholesterol levels","volume":"272","author":"Galioni","year":"1957","journal-title":"Lancet (London, England)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1096\/fj.01-0245com","article-title":"Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells","volume":"16","author":"Galon","year":"2002","journal-title":"FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib106","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.addr.2010.08.002","article-title":"Androgen receptor as a therapeutic target","volume":"62","author":"Gao","year":"2010","journal-title":"Advanced drug delivery reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib107","first-page":"3352","article-title":"Chemistry and structural biology of androgen receptor","volume":"105","author":"Gao","year":"2005","journal-title":"Chemical\u00a0Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100687","article-title":"Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era","volume":"296","author":"Gerber","year":"2021","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib109","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1124\/pr.58.4.2","article-title":"Overview of nomenclature of nuclear receptors","volume":"58","author":"Germain","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib110","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1365-2133.2007.07975.x","article-title":"The optimal use of bexarotene in cutaneous T\u2010cell lymphoma","volume":"157","author":"Gniadecki","year":"2007","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.10.001_bib111","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00002512-199812050-00006","article-title":"Bicalutamide in advanced prostate cancer","volume":"12","author":"Goa","year":"1998","journal-title":"Drugs & Aging"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib112","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.2.2.161","article-title":"Blood lipids and human atherosclerosis","volume":"2","author":"Gofman","year":"1950","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.10.001_bib113","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/106002809002400612","article-title":"Flutamide: An antiandrogen for advanced prostate cancer","volume":"24","author":"Goldspiel","year":"1990","journal-title":"DICP"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib114","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/j.2040-4603.2014.tb00569.x","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Comprehensive Physiology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s12964-024-01577-y","article-title":"CDK7 in breast cancer: Mechanisms of action and therapeutic potential","volume":"22","author":"Gong","year":"2024","journal-title":"Cell Communication and Signaling"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib116","series-title":"Encyclopedia of bone biology","first-page":"558","article-title":"Thyroid and bone","author":"Gouveia","year":"2020"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib117","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/320134a0","article-title":"Human oestrogen receptor cDNA: Sequence, expression and homology to v-erb-A","volume":"320","author":"Green","year":"1986","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib118","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/bph.15746","article-title":"Structural and molecular determinants of mineralocorticoid receptor signalling","volume":"179","author":"Grossmann","year":"2022","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib119","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1124\/jpet.106.116152","article-title":"Pharmacological profile of the thyroid hormone receptor antagonist NH3 in rats","volume":"322","author":"Grover","year":"2007","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.10.001_bib120","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1527-3466.2005.tb00161.x","article-title":"Development of the thyroid hormone receptor beta-subtype agonist KB-141: A strategy for body weight reduction and lipid lowering with minimal cardiac side effects","volume":"23","author":"Grover","year":"2005","journal-title":"Cardiovascular Drug Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib121","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.1073\/pnas.1633737100","article-title":"Selective thyroid hormone receptor-beta activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability","volume":"100","author":"Grover","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib122","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1210\/en.2013-1473","article-title":"Analysis of glucocorticoid receptors and their apoptotic response to dexamethasone in male murine B cells during development","volume":"155","author":"Gruver-Yates","year":"2014","journal-title":"Endocrinology"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.10.001_bib123","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S1470-2045(22)00507-1","article-title":"Rezvilutamide versus bicalutamide in combination with androgen-deprivation therapy in patients with high-volume, metastatic, hormone-sensitive prostate cancer (chart): A randomised, open-label, phase 3 trial","volume":"23","author":"Gu","year":"2022","journal-title":"The Lancet Oncology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib124","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jsbmb.2012.08.004","article-title":"Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and letrozole resistant T47D breast cancer cells","volume":"133","author":"Gupta","year":"2013","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib125","doi-asserted-by":"crossref","first-page":"270","DOI":"10.7326\/0003-4819-132-4-200002150-00004","article-title":"Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: The Rotterdam Study","volume":"132","author":"Hak","year":"2000","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib126","unstructured":"Hariri, L., & Rehman, A. (2019). Estradiol."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib127","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet (London, England)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib128","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.10.001_bib129","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126329","article-title":"Myelin repair stimulated by CNS-selective thyroid hormone action","volume":"4","author":"Hartley","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib130","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/en.2016-1842","article-title":"A thyroid hormone-based strategy for correcting the biochemical abnormality in X-linked adrenoleukodystrophy","volume":"158","author":"Hartley","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib131","doi-asserted-by":"crossref","first-page":"37219","DOI":"10.1074\/jbc.274.52.37219","article-title":"Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH2-terminal domain","volume":"274","author":"He","year":"1999","journal-title":"Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.10.001_bib132","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib133","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1210\/endo-34-6-416","article-title":"The influence of 11-dehydr0-17-hydr0xycorticosterone (compound E) On the growth of a malignant tumor in the mouse11","volume":"34","author":"Heilman","year":"1944","journal-title":"Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib134","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23052698","article-title":"Subcellular distribution of thyroid hormone receptor beta in ovarian cancer","volume":"23","author":"Heublein","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib135","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.mce.2011.07.017","article-title":"Structural and functional analysis of domains of the progesterone receptor","volume":"348","author":"Hill","year":"2012","journal-title":"Molecular and Cellular Endocrinology"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.10.001_bib136","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00001703-200206000-00013","article-title":"Mifepristone: Contraceptive and non-contraceptive uses","volume":"14","author":"Ho","year":"2002","journal-title":"Current Opinion in Obstetrics and Gynecology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib137","series-title":"Systematic review of treatments for atopic eczema","article-title":"Topical corticosteroids","author":"Hoare","year":"2000"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib138","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.csbj.2023.02.015","article-title":"Machine learning reveals STAT motifs as predictors for GR-mediated gene repression","volume":"21","author":"H\u00f6llbacher","year":"2023","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib139","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/318635a0","article-title":"Primary structure and expression of a functional human glucocorticoid receptor cDNA","volume":"318","author":"Hollenberg","year":"1985","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib140","doi-asserted-by":"crossref","first-page":"11928","DOI":"10.1016\/S0021-9258(19)38489-3","article-title":"Mapping the HSP90 binding region of the glucocorticoid receptor","volume":"265","author":"Howard","year":"1990","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib141","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s40265-023-01861-0","article-title":"Elacestrant:\u00a0First approval","volume":"83","author":"Hoy","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib142","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1389200219666180925091851","article-title":"A review of recent advances and research on drug target identification methods","volume":"20","author":"Hu","year":"2019","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib143","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2165\/00128071-200607030-00002","article-title":"Management of refractory early-stage cutaneous T-cell lymphoma","volume":"7","author":"Huber","year":"2006","journal-title":"American journal of clinical dermatology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib144","series-title":"StatPearls [Internet]","article-title":"Eplerenone","author":"Hughes","year":"2023"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib145","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051702","article-title":"Liothyronine for hypothyroidism: A candidate for disinvestment or in need of further research? A value of information analysis","volume":"11","author":"Hughes","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib146","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/jm201546m","article-title":"Synthesis and evaluation of sulfonylnitrophenylthiazoles (SNPTs) as thyroid hormone receptor\u2013coactivator interaction inhibitors","volume":"55","author":"Hwang","year":"2012","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib147","doi-asserted-by":"crossref","first-page":"11895","DOI":"10.1074\/jbc.M110.200436","article-title":"Methylsulfonylnitrobenzoates, a new class of irreversible inhibitors of the interaction of the thyroid hormone receptor and its obligate coactivators that functionally antagonizes thyroid hormone","volume":"286","author":"Hwang","year":"2011","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib148","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1074\/jbc.M008384200","article-title":"Estrogen receptor binding to DNA is not required for its activity through the nonclassical AP1 pathway","volume":"276","author":"Jakacka","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"15","key":"10.1016\/bs.apcsb.2024.10.001_bib149","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s40265-017-0791-4","article-title":"Potential role of thyroid receptor \u03b2 agonists in the treatment of hyperlipidemia","volume":"77","author":"Jakobsson","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1353\/pbm.1963.0005","article-title":"On the mechanism of estrogen action","volume":"6","author":"Jensen","year":"1962","journal-title":"Perspectives in Biology and Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib151","first-page":"387","volume":"18","author":"Jensen","year":"1962","journal-title":"Basic guides to the mechanism of estrogen action. Recent prog horm res"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib152","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.beem.2015.04.008","article-title":"Estrogen receptor alpha and beta in health and disease","volume":"29","author":"Jia","year":"2015","journal-title":"Best practice & research Clinical endocrinology & metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib153","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0304-3835(98)00382-6","article-title":"The RAR\u03b3 selective agonist CD437 inhibits gastric cell growth through the mechanism of apoptosis.","volume":"137","author":"Jiang","year":"1999","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib154","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1038\/s41467-021-22234-9","article-title":"Genome-wide binding potential and regulatory activity of the glucocorticoid receptor\u2019s monomeric and dimeric forms","volume":"12","author":"Johnson","year":"2021","journal-title":"Nature Communications"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.10.001_bib155","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/annonc\/mdt216","article-title":"Randomized phase II study of Lonaprisan as second-line therapy for progesterone receptor-positive breast cancer","volume":"24","author":"Jonat","year":"2013","journal-title":"Annals of Oncology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib156","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.tips.2013.07.003","article-title":"Glucocorticoid receptor signaling in health and disease","volume":"34","author":"Kadmiel","year":"2013","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib157","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.coph.2020.10.007","article-title":"Corticosteroids and circadian rhythms in the cardiovascular system","volume":"57","author":"Kanki","year":"2021","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib158","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.ejmech.2016.08.011","article-title":"Oxindole: A chemical prism carrying plethora of therapeutic benefits","volume":"123","author":"Kaur","year":"2016","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib159","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s40265-024-02045-0","article-title":"Resmetirom: First approval","volume":"84","author":"Keam","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/jmbi.2000.4032","article-title":"Structural basis for isotype selectivity of the human retinoic acid nuclear receptor","volume":"302","author":"Klaholz","year":"2000","journal-title":"Journal of molecular biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib161","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2013.11.010","article-title":"Tracking progesterone receptor-mediated actions in breast cancer","volume":"142","author":"Knutson","year":"2014","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib162","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1210\/js.2019-00158","article-title":"Glucocorticoid and mineralocorticoid receptors in the brain: A transcriptional perspective","volume":"3","author":"Koning","year":"2019","journal-title":"Journal of the Endocrine Society"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib163","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.steroids.2016.06.007","article-title":"Nuclear and extranuclear-initiated estrogen receptor signaling crosstalk and endocrine resistance in breast cancer","volume":"114","author":"Kulkoyluoglu","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/me.2002-0258","article-title":"Transactivation functions of the N-terminal domains of nuclear hormone receptors: Protein folding and coactivator interactions","volume":"17","author":"Kumar","year":"2003","journal-title":"Molecular Endocrinology"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.10.001_bib165","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1210\/jcem-69-2-461","article-title":"3,5,3\u2019-triiodothyroacetic acid therapy for thyroid hormone resistance","volume":"69","author":"Kunitake","year":"1989","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.10.001_bib166","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1210\/jc.2009-1209","article-title":"Effects of the Thyromimetic Agent Diiodothyropropionic Acid on Body Weight, Body Mass Index, and Serum Lipoproteins: A Pilot Prospective, Randomized, Controlled Study","volume":"95","author":"Ladenson","year":"2010","journal-title":"The Journal of Clinical Endocrinology & Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib167","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1016\/j.leukres.2009.04.018","article-title":"Prednisolone exerts late mitogenic and biphasic effects on resistant acute lymphoblastic leukemia cells: Relation to early gene expression","volume":"33","author":"Lambrou","year":"2009","journal-title":"Leukemia Research"},{"issue":"2","key":"10.1016\/bs.apcsb.2024.10.001_bib168","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14728222.2016.1090429","article-title":"Sobetirome: The past, present and questions about the future","volume":"20","author":"Lammel Lindemann","year":"2016","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib169","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1073\/pnas.84.9.2877","article-title":"The progesterone receptor gene maps to human chromosome band 11q13, the site of the mammary oncogene int-2","volume":"84","author":"Law","year":"1987","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib170","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4161\/derm.1.3.9364","article-title":"The use of isotretinoin in acne","volume":"1","author":"Layton","year":"2009","journal-title":"Dermato-endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108561","article-title":"Retinoid X receptor agonists as selective modulators of the immune system for the treatment of cancer","author":"Leal","year":"2023","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib172","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: A review","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib173","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0039-128X(03)00129-6","article-title":"Progesterone receptor transcription and non-transcription signaling mechanisms","volume":"68","author":"Leonhardt","year":"2003","journal-title":"Steroids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib174","doi-asserted-by":"crossref","first-page":"408","DOI":"10.18632\/oncotarget.28191","article-title":"The long winding road to the safer glucocorticoid receptor (GR) targeting therapies","volume":"13","author":"Lesovaya","year":"2022","journal-title":"Oncotarget"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib175","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41574-022-00683-6","article-title":"Fresh insights into glucocorticoid-induced diabetes mellitus and new therapeutic directions","volume":"18","author":"Li","year":"2022","journal-title":"Nature Reviews Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib176","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/med.21558","article-title":"A magic drug target: Androgen receptor","volume":"39","author":"Li","year":"2019","journal-title":"Medicinal research reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib177","first-page":"515","article-title":"The constitution of a progesterone response element","volume":"7","author":"Lieberman","year":"1993","journal-title":"Molecular Endocrinology (Baltimore, Md.)"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib178","doi-asserted-by":"crossref","first-page":"35664","DOI":"10.1074\/jbc.M205608200","article-title":"A thyroid hormone antagonist that inhibits thyroid hormone action in vivo","volume":"277","author":"Lim","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib179","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.steroids.2016.02.019","article-title":"New dimension of glucocorticoids in cancer treatment","volume":"111","author":"Lin","year":"2016","journal-title":"Steroids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib180","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1210\/endrev\/bnae008","article-title":"The glucocorticoid receptor: Isoforms, functions, and contribution to glucocorticoid sensitivity","volume":"45","author":"Lockett","year":"2024","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib181","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tcb.2006.04.005","article-title":"Glucocorticoid receptor isoforms generate transcription specificity","volume":"16","author":"Lu","year":"2006","journal-title":"Trends in Cell Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib182","series-title":"Vitamins and Hormones","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/bs.vh.2017.04.004","article-title":"Thyroid hormone receptor antagonists: From environmental pollution to novel small molecules","author":"Mackenzie","year":"2018"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.10.001_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2019.11.002","article-title":"Phase 2 study of Seviteronel (INO-464) in patients with metastatic castration-resistant prostate cancer after enzalutamide treatment","volume":"18","author":"Madan","year":"2020","journal-title":"Clinical Genitourinary Cancer"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib184","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.2174\/092986709788803277","article-title":"Thyroid hormone antagonists: Potential medical applications and structure activity relationships","volume":"16","author":"Malm","year":"2009","journal-title":"Current Medicinal Chemistry"},{"issue":"6","key":"10.1016\/bs.apcsb.2024.10.001_bib185","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: The second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.10.001_bib186","doi-asserted-by":"crossref","first-page":"100893","DOI":"10.1016\/j.tranon.2020.100893","article-title":"9-cis-UAB30, a novel Rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts","volume":"14","author":"Marayati","year":"2021","journal-title":"Translational Oncology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib187","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2337\/cd21-0050","article-title":"Finerenone","volume":"39","author":"Marcath","year":"2021","journal-title":"Clinical Diabetes"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.715752","article-title":"A retinoid X receptor agonist directed to the large intestine ameliorates T-cell-mediated colitis in mice","volume":"12","author":"Matsumoto","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib189","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.mce.2011.06.014","article-title":"Mineralocorticoid receptors in vascular function and disease","volume":"350","author":"McCurley","year":"2012","journal-title":"Molecular and cellular endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","article-title":"The epidemiology of glucocorticoid-associated adverse events","volume":"20","author":"McDonough","year":"2008","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib191","first-page":"321","article-title":"Nuclear receptor coregulators: Cellular and molecular biology","volume":"20","author":"McKenna","year":"1999","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib192","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.287.5456.1262","article-title":"The glucocorticoid receptor: Rapid exchange with regulatory sites in living cells","volume":"287","author":"McNally","year":"2000","journal-title":"Science"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.10.001_bib193","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1073\/pnas.69.5.1146","article-title":"Ovalbumin messenger RNA of chick oviduct: Partial characterization, estrogen dependence, and translation in vitro","volume":"69","author":"Means","year":"1972","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib194","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ando.2018.03.004","article-title":"Glucocorticoid receptor modulators","volume":"79","author":"Meijer","year":"2018","journal-title":"Annales D\u2019endocrinologie"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib195","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1021\/acschemneuro.7b00239","article-title":"Targeting fatty-acid amide hydrolase with prodrugs for CNS-selective therapy","volume":"8","author":"Meinig","year":"2017","journal-title":"ACS Chemical Neuroscience"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib196","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1093\/emboj\/cdg295","article-title":"The thyroid hormone receptor antagonizes CREB-mediated transcription","volume":"22","author":"M\u00e9ndez-Pertuz","year":"2003","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib197","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3390\/biomedicines8100422","article-title":"The androgen receptor in prostate cancer: Effect of structure, ligands and spliced variants on therapy","volume":"8","author":"Messner","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib198","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0968-0004(91)90168-U","article-title":"Regulatory crosstalk at composite response elements","volume":"16","author":"Miner","year":"1991","journal-title":"Trends in Biochemical Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib199","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1073\/pnas.85.16.5804","article-title":"Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone","volume":"85","author":"Mitsuhashi","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib200","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1172\/JCI63067","article-title":"Thymocyte responsiveness to endogenous glucocorticoids is required for immunological fitness","volume":"122","author":"Mittelstadt","year":"2012","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib201","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1089\/thy.2007.0248","article-title":"Metabolic effects of thyroid hormone derivatives","volume":"18","author":"Moreno","year":"2008","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib202","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/ncomms5456","article-title":"Single molecule analysis of transcription factor binding at transcription sites in live cells","volume":"5","author":"Morisaki","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib203","doi-asserted-by":"crossref","first-page":"1200947","DOI":"10.3389\/fmed.2023.1200947","article-title":"Targeting nuclear hormone receptors for the prevention of breast cancer","volume":"10","author":"Moyer","year":"2023","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib204","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1101\/gad.13.24.3209","article-title":"Mechanism of corepressor binding and release from nuclear hormone receptors","volume":"13","author":"Nagy","year":"1999","journal-title":"Genes & Development"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib205","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.kisu.2021.11.004","article-title":"Nonepithelial mineralocorticoid receptor activation as a determinant of kidney disease","volume":"12","author":"Nakamura","year":"2022","journal-title":"Kidney International Supplements"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib206","unstructured":"NCI Drug Dictionary (no date) Comprehensive Cancer Information - NCI. Available at: https:\/\/www.cancer.gov\/publications\/dictionaries\/cancer-drug\/def\/retinoid-x-receptor-agonist-irx4204 (Accessed: 30 October 2024)."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib207","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1172\/JCI33869","article-title":"Neutrophil gelatinase\u2013associated lipocalin mediates 13-cis retinoic acid\u2013induced apoptosis of human sebaceous gland cells","volume":"118","author":"Nelson","year":"2008","journal-title":"The Journal of clinical investigation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.maturitas.2005.03.010","article-title":"Comparing raloxifene with continuous combined estrogen\u2013progestin therapy in postmenopausal women: Review of Euralox 1","volume":"52","author":"Neven","year":"2005","journal-title":"Maturitas"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib209","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.1021\/jm0201013","article-title":"Rational design and synthesis of a novel thyroid hormone antagonist that blocks coactivator recruitment","volume":"45","author":"Nguyen","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.10.001_bib210","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2009.09.002","article-title":"The human glucocorticoid receptor: Molecular basis of biologic function","volume":"75","author":"Nicolaides","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib211","first-page":"9","article-title":"Incidence and health care burden of uterine fibroids among female service members in the active component of the US Armed Forces, 2011\u20132022","volume":"31","author":"Nieh","year":"2024","journal-title":"Medical Surveillance Monthly Report"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib212","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1172\/JCI113874","article-title":"Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells","volume":"83","author":"Norman","year":"1989","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib213","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1210\/me.2003-0044","article-title":"Genomic targets of nuclear estrogen receptors","volume":"18","author":"O\u2019Lone","year":"2004","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib214","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1074\/jbc.R110.179325","article-title":"Cellular processing of the glucocorticoid receptor gene and protein: New mechanisms for generating tissue-specific actions of glucocorticoids","volume":"286","author":"Oakley","year":"2011","journal-title":"The Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.10.001_bib215","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","article-title":"The biology of the glucocorticoid receptor: New signaling mechanisms in health and disease","volume":"132","author":"Oakley","year":"2013","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib216","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/JME-15-0318","article-title":"Mineralocorticoid regulation of cell function: The role of rapid signalling and gene transcription pathways","volume":"58","author":"Ong","year":"2017","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib217","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI111667","article-title":"Stereospecific transport of triiodothyronine from plasma to cytosol and from cytosol to nucleus in rat liver, kidney, brain, and heart","volume":"75","author":"Oppenheimer","year":"1985","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.10.001_bib218","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","article-title":"Long-term side effects of glucocorticoids","volume":"15","author":"Oray","year":"2016","journal-title":"Expert Opinion on Drug Safety"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib219","doi-asserted-by":"crossref","DOI":"10.1016\/j.intcar.2020.100016","article-title":"Management of chronic heart failure","volume":"2","author":"Osmanska","year":"2020","journal-title":"Clinics in Integrated Care"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib220","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1128\/MCB.17.2.895","article-title":"Glucocorticoid receptor-glucocorticoid response element binding stimulates nucleosome disruption by the SWI\/SNF complex","volume":"17","author":"\u00d6stlund Farrants","year":"1997","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib221","doi-asserted-by":"crossref","first-page":"8216","DOI":"10.1038\/srep08216","article-title":"Structural basis of natural promoter recognition by the retinoid X nuclear receptor","volume":"5","author":"Osz","year":"2015","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib222","doi-asserted-by":"crossref","DOI":"10.1002\/9783527623297.ch1","article-title":"Nuclear receptors as drug targets: A historical perspective of modern drug discovery","author":"Ottow","year":"2008","journal-title":"Nuclear Receptors as Drug Targets"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib223","doi-asserted-by":"crossref","first-page":"20479","DOI":"10.1074\/jbc.270.35.20479","article-title":"The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor","volume":"270","author":"Owens-Grillo","year":"1995","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib224","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1038\/s41388-020-1284-6","article-title":"Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities","volume":"39","author":"Pancholi","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib225","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18102201","article-title":"Treatment with synthetic glucocorticoids and the hypothalamus-pituitary-adrenal axis","volume":"18","author":"Paragliola","year":"2017","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2017.12.012","article-title":"Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment","volume":"186","author":"Patel","year":"2018","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib227","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/me.2014-1062","article-title":"Minireview: New molecular mediators of glucocorticoid receptor activity in metabolic tissues","volume":"28","author":"Patel","year":"2014","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib228","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): Subtype-selective ligands and clinical potential","volume":"90","author":"Paterni","year":"2014","journal-title":"Steroids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib229","unstructured":"Patibandla, S., Heaton, J., & Kyaw, H. (2020). Spironolactone."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib230","series-title":"eLS","article-title":"History of cortisone and related compounds","author":"Patrick","year":"2013"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib231","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/156802612799436641","article-title":"General molecular biology and architecture of nuclear receptors","volume":"12","author":"Pawlak","year":"2012","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib232","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/1097-0142(194911)2:6<943::AID-CNCR2820020602>3.0.CO;2-P","article-title":"Adrenocorticotropic hormone- and cortisone-induced regression of lymphoid tumors in man; a preliminary report","volume":"2","author":"Pearson","year":"1949","journal-title":"Cancer"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib233","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1950.02920160023005","article-title":"Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in lymphomas and leukemias","volume":"144","author":"Pearson","year":"1950","journal-title":"Journal of the American Medical Association"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib234","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrm1680","article-title":"Controlling nuclear receptors: The circular logic of cofactor cycles","volume":"6","author":"Perissi","year":"2005","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib235","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12808","article-title":"Potential role of two novel agonists of thyroid hormone receptor-\u03b2 on liver regeneration","volume":"53","author":"Perra","year":"2020","journal-title":"Cell Proliferation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib236","doi-asserted-by":"crossref","first-page":"22396","DOI":"10.1038\/srep22396","article-title":"All trans-retinoic acid analogs promote cancer cell apoptosis through non-genomic Crabp1 mediating ERK1\/2 phosphorylation","volume":"6","author":"Persaud","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib237","first-page":"133","article-title":"Ulipristal acetate as a treatment option for uterine fibroids.","volume":"16","author":"Piecak","year":"2017","journal-title":"Menopause Review\/Przegl\u0105d Menopauzalny"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib238","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3390\/ph17040418","article-title":"Finerenone: From the mechanism of action to clinical use in kidney disease","volume":"17","author":"Piko","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib239","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/sj.leu.2405039","article-title":"The BCL2 rheostat in glucocorticoid-induced apoptosis of acute lymphoblastic leukemia","volume":"22","author":"Ploner","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jsbmb.2004.12.017","article-title":"Glucocorticoid-induced apoptosis and glucocorticoid resistance in acute lymphoblastic leukemia","volume":"93","author":"Ploner","year":"2005","journal-title":"The Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib241","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/cancers11121852","article-title":"Structure and function of the nuclear receptor superfamily and current targeted therapies of prostate cancer","volume":"11","author":"Porter","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib242","unstructured":"PubChem, 2024 Available at: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Elacestrant (Accessed: 28 August 2024)."},{"key":"10.1016\/bs.apcsb.2024.10.001_bib243","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-2895-8_14","article-title":"Glucocorticoids and cancer","volume":"872","author":"Pufall","year":"2015","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib244","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1158\/2159-8290.CD-17-1229","article-title":"Discovery of selective estrogen receptor covalent antagonists for the treatment of ER\u03b1WT and ER\u03b1MUT breast cancer","volume":"8","author":"Puyang","year":"2018","journal-title":"Cancer Discovery"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.10.001_bib245","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1113\/jphysiol.2014.282871","article-title":"Cushing\u2019s syndrome: From physiological principles to diagnosis and clinical care","volume":"593","author":"Raff","year":"2015","journal-title":"The Journal of physiology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib246","series-title":"StatPearls [Internet]","article-title":"Fludrocortisone","author":"Rahman","year":"2023"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib247","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids-mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib248","doi-asserted-by":"crossref","first-page":"12622","DOI":"10.3390\/ijms232012622","article-title":"The use of retinoids for the prevention and treatment of skin cancers: An updated review","volume":"23","author":"Ramchatesingh","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib249","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd3478","article-title":"Trends in the exploitation of novel drug targets","volume":"10","author":"Rask-Andersen","year":"2011","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib250","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JME-13-0173","article-title":"Understanding nuclear receptor form and function using structural biology","volume":"51","author":"Rastinejad","year":"2013","journal-title":"Journal of Molecular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib251","doi-asserted-by":"crossref","unstructured":"Rathkopf, D. E. et al. (2018) \u2018An open-label phase 1\/2A study to evaluate the safety, pharmacokinetics, pharmacodynamics, and preliminary efficacy of TRC253, an androgen receptor antagonist, in patients with metastatic castration-resistant prostate cancer (mcrpc).\u2019, Journal of Clinical Oncology, 36(6_suppl). https:\/\/doi.org\/10.1200\/jco.2018.36.6_suppl.tps403.","DOI":"10.1200\/JCO.2018.36.6_suppl.TPS403"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib252","first-page":"348","article-title":"The syndromes of resistance to thyroid hormone","volume":"14","author":"Refetoff","year":"1993","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib253","doi-asserted-by":"crossref","DOI":"10.1016\/j.endmts.2023.100144","article-title":"Thyroid hormone receptor beta: Relevance in human health and diseases","volume":"13","author":"Rehman","year":"2023","journal-title":"Endocrine and Metabolic Science"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib254","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198803103181003","article-title":"Long-term growth in juvenile acquired hypothyroidism","volume":"318","author":"Rivkees","year":"1988","journal-title":"New England Journal of Medicine"},{"issue":"26","key":"10.1016\/bs.apcsb.2024.10.001_bib255","doi-asserted-by":"crossref","first-page":"16701","DOI":"10.1073\/pnas.262671599","article-title":"Alternate surfaces of transcriptional coregulator GRIP1 function in different glucocorticoid receptor activation and repression contexts","volume":"99","author":"Rogatsky","year":"2002","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib256","doi-asserted-by":"crossref","first-page":"112006","DOI":"10.1016\/j.ejmech.2019.112006","article-title":"Design, synthesis and biological evaluation of novel TR\u03b2 selective agonists sustained by ADME-toxicity analysis","volume":"188","author":"Runfola","year":"2020","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib257","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.34864","article-title":"Gene-specific mechanisms direct glucocorticoid-receptor-driven repression of inflammatory response genes in macrophages","volume":"7","author":"Sacta","year":"2018","journal-title":"Elife"},{"issue":"10","key":"10.1016\/bs.apcsb.2024.10.001_bib258","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1021\/cb200092v","article-title":"Similarities and differences between two modes of antagonism of the thyroid hormone receptor","volume":"6","author":"Sadana","year":"2011","journal-title":"ACS Chemical Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib259","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/324635a0","article-title":"The c-erb-A protein is a high-affinity receptor for thyroid hormone","volume":"324","author":"Sap","year":"1986","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib260","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2020.00331","article-title":"Selective thyroid hormone receptor-beta (TR\u03b2) agonists: New perspectives for the treatment of metabolic and neurodegenerative disorders","volume":"7","author":"Saponaro","year":"2020","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib261","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0163-7258(02)00297-8","article-title":"Mechanisms involved in the side effects of glucocorticoids","volume":"96","author":"Sch\u00e4cke","year":"2002","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib262","first-page":"215","article-title":"Enzalutamide: Targeting the androgen signalling pathway in metastatic castration\u2010resistant prostate cancer","volume":"117","author":"Schalken","year":"2016","journal-title":"BJU\u00a0International"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.10.001_bib263","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1073\/pnas.1131854100","article-title":"Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking","volume":"100","author":"Schapira","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib264","series-title":"Encyclopedia of toxicology (Second Edition)","first-page":"98","article-title":"Amiodarone","author":"Scharman","year":"2005"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib265","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/s13059-014-0418-y","article-title":"Glucocorticoid receptor binds half sites as a monomer and regulates specific target genes","volume":"15","author":"Schiller","year":"2014","journal-title":"Genome Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib266","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/sj.cdd.4401456","article-title":"Glucocorticoid-induced apoptosis and glucocorticoid resistance: Molecular mechanisms and clinical relevance","volume":"11","author":"Schmidt","year":"2004","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib267","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1182\/blood-2005-07-2853","article-title":"Identification of glucocorticoid-response genes in children with acute lymphoblastic leukemia","volume":"107","author":"Schmidt","year":"2006","journal-title":"Blood"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib268","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1210\/endo-113-4-1236","article-title":"Distribution and metabolism of L- and DTriiodothyronine (T3) in the rat: Preferential accumulation of L-T3 by hepatic and cardiac nuclei as a probable explanation of the differential biological potency of T3 enantiomers","volume":"113","author":"Schwartz","year":"1983","journal-title":"Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib269","first-page":"1277","article-title":"The aftermath of childhood hyperthyroidism","volume":"14","author":"Segni","year":"2001","journal-title":"Journal of Pediatric Endocrinology & Metabolism: JPEM"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib270","doi-asserted-by":"crossref","first-page":"a016709","DOI":"10.1101\/cshperspect.a016709","article-title":"Signaling by nuclear receptors","volume":"5","author":"Sever","year":"2013","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib271","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cpet.2015.05.007","article-title":"PET\/computed tomography using new radiopharmaceuticals in targeted therapy","volume":"10","author":"Sharma","year":"2015","journal-title":"PET Clinics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib272","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s12035-021-02709-y","article-title":"Retinoid X receptor: Cellular and biochemical roles of nuclear receptor with a focus on neuropathological involvement","volume":"59","author":"Sharma","year":"2022","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib273","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4158\/EP12086.RA","article-title":"Thyroid hormone analogues for the treatment of metabolic disorders: New potential for unmet clinical needs?","volume":"18","author":"Shoemaker","year":"2012","journal-title":"Endocrine Practice"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib274","series-title":"Endotext. MDText.com, Inc","article-title":"Cellular Action of Thyroid Hormone","author":"Sinha","year":"2000"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib275","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-230X(08)00406-5","article-title":"Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis","volume":"101","author":"Sionov","year":"2008","journal-title":"Advances in Cancer Research"},{"issue":"15","key":"10.1016\/bs.apcsb.2024.10.001_bib276","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1715546","article-title":"Apalutamide treatment and metastasis-free survival in prostate cancer","volume":"378","author":"Smith","year":"2018","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib277","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6123(10)82001-1","article-title":"Glucocorticoid-induced apoptosis of healthy and malignant lymphocytes","volume":"182","author":"Smith","year":"2010","journal-title":"Progress in Brain Research"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.10.001_bib278","first-page":"218","article-title":"Effect of thyroid extract on serum lipoproteins and serum cholesterol","volume":"3","author":"Strisower","year":"1954","journal-title":"Metabolism: Clinical and Experimental"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.10.001_bib279","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1210\/jcem-15-1-73","article-title":"Effect of long-term administration of desiccated thyroid on serum lipoprotein and cholesterol levels","volume":"15","author":"Strisower","year":"1955","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib280","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.steroids.2017.11.002","article-title":"Glucocorticoid receptor signaling in the eye","volume":"133","author":"Sulaiman","year":"2018","journal-title":"Steroids"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib281","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.pharmthera.2015.05.001","article-title":"Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds","volume":"152","author":"Sundahl","year":"2015","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib282","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cell.2011.03.027","article-title":"Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor","volume":"145","author":"Surjit","year":"2011","journal-title":"Cell"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib283","doi-asserted-by":"crossref","unstructured":"Surya K. De, (2023). Chapter 3 - Hormonal therapy, Editor(s): Surya K. De, Medicines for Cancer, Elsevier, Pages 161-204, ISBN 9780443133121.","DOI":"10.1016\/B978-0-443-13312-1.00006-4"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib284","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1038\/sj.cdd.4401533","article-title":"Retinoid X receptors: X-ploring their (patho) physiological functions","volume":"11","author":"Szanto","year":"2004","journal-title":"Cell Death & Differentiation"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: Structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib286","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pharmthera.2011.04.003","article-title":"Thyromimetics: A journey from bench to bed-side","volume":"131","author":"Tancevski","year":"2011","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib287","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.802699","article-title":"Selective retinoic acid receptor \u03b3 antagonist 7C is a potent enhancer of BMP-induced ectopic endochondral bone formation","volume":"10","author":"Tateiwa","year":"2022","journal-title":"Frontiers in Cell and Developmental Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib288","doi-asserted-by":"crossref","unstructured":"Tavares, L. C. P., Caetano, L. de V. N., & Ianhez, M. (2024). Side effects of chronic systemic glucocorticoid therapy: What dermatologists should know. Anais Brasileiros de Dermatologia, 99(2), 259\u2013268. https:\/\/doi.org\/10.1016\/j.abd.2023.05.005.","DOI":"10.1016\/j.abd.2023.05.005"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib289","first-page":"313","article-title":"Mineralocorticoid receptor signaling as a therapeutic target for renal and cardiac fibrosis","volume":"8","author":"Tesch","year":"2017","journal-title":"Frontiers in\u00a0Pharmacology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib290","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/jama.1972.03200070084015","article-title":"Findings leading to further modifications of its protocol with respect to dextrothyroxine","volume":"220","year":"1972","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/bs.apcsb.2024.10.001_bib291","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3390\/ijms25031817","article-title":"Treatments targeting the androgen receptor and its splice variants in breast cancer","volume":"25","author":"Tien","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib292","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fimmu.2019.01545","article-title":"A general introduction to glucocorticoid biology","volume":"10","author":"Timmermans","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib293","doi-asserted-by":"crossref","first-page":"3929","DOI":"10.1182\/blood-2006-11-056366","article-title":"Genomewide identification of prednisolone-responsive genes in acute lymphoblastic leukemia cells","volume":"109","author":"Tissing","year":"2007","journal-title":"Blood"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib294","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1073\/pnas.55.6.1574","article-title":"A receptor molecule for estrogens: Isolation from the rat uterus and preliminary characterization","volume":"55","author":"Toft","year":"1966","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib295","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.eprac.2021.02.002","article-title":"Subclinical hyperthyroidism: A review of the clinical literature","volume":"27","author":"Tsai","year":"2021","journal-title":"Endocrine Practice"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib296","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1056\/NEJMoa2214131","article-title":"Capivasertib in hormone receptor\u2013positive advanced breast cancer","volume":"388","author":"Turner","year":"2023","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1016\/bs.apcsb.2024.10.001_bib297","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2012-2556","article-title":"Diiodothyropropionic Acid (DITPA) in the Treatment of MCT8 Deficiency","volume":"97","author":"Verge","year":"2012","journal-title":"The Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1016\/bs.apcsb.2024.10.001_bib298","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.eururo.2022.07.014","article-title":"Re: Darolutamide and survival in metastatic, hormone-sensitive prostate cancer","volume":"82","author":"Vilaseca","year":"2022","journal-title":"European Urology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib299","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cell.2011.07.006","article-title":"Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism","volume":"146","author":"Voss","year":"2011","journal-title":"Cell"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib300","first-page":"329","article-title":"The many faces of estrogen signaling","volume":"24","author":"Vrta\u010dnik","year":"2014","journal-title":"Biochemia\u00a0Medica"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib301","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/378690a0","article-title":"A structural role for hormone in the thyroid hormone receptor","volume":"378","author":"Wagner","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib302","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.21037\/tcr-20-2166","article-title":"Fulvestrant as a reference antiestrogen and estrogen receptor (ER) degrader in preclinical studies: Treatment dosage, efficacy, and implications on development of new ER-targeting agents","volume":"9","author":"Wang","year":"2020","journal-title":"Translational Cancer Research"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib303","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1016\/j.apsb.2023.05.005","article-title":"Discovery of novel covalent selective estrogen receptor degraders against endocrine-resistant breast cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib304","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.3390\/cells12212575","article-title":"Development of bexarotene analogs for treating cutaneous T-cell lymphomas","volume":"12","author":"Warda","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib305","doi-asserted-by":"crossref","first-page":"15014","DOI":"10.1074\/jbc.M001007200","article-title":"Architectural principles for the structure and function of the glucocorticoid receptor tau 1 core activation domain","volume":"275","author":"W\u00e4rnmark","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib306","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1210\/me.2002-0384","article-title":"Activation functions 1 and 2 of nuclear receptors: Molecular strategies for transcriptional activation","volume":"17","author":"W\u00e4rnmark","year":"2003","journal-title":"Molecular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib307","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.mce.2011.08.033","article-title":"Nuclear hormone receptor co-repressors: Structure and function","volume":"348\u2013135","author":"Watson","year":"2012","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib308","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/pro.3496","article-title":"The nuclear receptor superfamily: A structural perspective","volume":"27","author":"Weikum","year":"2018","journal-title":"Protein Science: A Publication of the Protein Society"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib309","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/318670a0","article-title":"Domain structure of human glucocorticoid receptor and its relationship to the v-erb-A oncogene product","volume":"318","author":"Weinberger","year":"1985","journal-title":"Nature"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib310","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.3390\/ijerph20043578","article-title":"Disparities in cutaneous T-cell lymphoma incidence by race\/ethnicity and area-based socioeconomic status","volume":"20","author":"Wiese","year":"2023","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib311","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/emboj\/17.2.455","article-title":"Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor alpha 1","volume":"17","author":"Wikstr\u00f6m","year":"1998","journal-title":"The EMBO Journal"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib312","doi-asserted-by":"crossref","first-page":"8329","DOI":"10.1128\/MCB.20.22.8329-8342.2000","article-title":"Cloning and characterization of two novel thyroid hormone receptor beta isoforms","volume":"20","author":"Williams","year":"2000","journal-title":"Molecular and Cellular Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib313","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116779","article-title":"Halogenated retinoid derivatives as dual RAR\u03b1 and RXR\u03b1 modulators for treating acute promyelocytic leukemia cells","author":"Xu","year":"2024","journal-title":"European Journal of Medicinal Chemistry"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib314","first-page":"255","article-title":"Localization and functions of steroid hormone receptors","volume":"13","author":"Yamashita","year":"1998","journal-title":"Histology and Histopathology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib315","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/rmb2.12006","article-title":"Molecular mechanism of estrogen\u2013estrogen receptor signaling","volume":"16","author":"Ya\u015far","year":"2017","journal-title":"Reproductive Medicine and Biology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib316","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1152\/physrev.2001.81.3.1097","article-title":"Physiological and molecular basis of thyroid hormone action","volume":"81","author":"Yen","year":"2001","journal-title":"Physiological Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib317","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1124\/mol.104.003475","article-title":"A retinoic acid receptor \u03b2\/\u03b3-selective prodrug (tazarotene) plus a retinoid X receptor ligand induces extracellular signal-regulated kinase activation, retinoblastoma hypophosphorylation, G0 arrest, and cell differentiation","volume":"66","author":"Yen","year":"2004","journal-title":"Molecular Pharmacology"},{"issue":"8","key":"10.1016\/bs.apcsb.2024.10.001_bib318","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/1878-0261.13641","article-title":"tas3681, an androgen receptor antagonist, prevents drug resistance driven by aberrant androgen receptor signaling in prostate cancer","volume":"18","author":"Yoshida","year":"2024","journal-title":"Molecular Oncology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib319","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1507\/endocrj.KR-80","article-title":"Aldosterone as a cardiovascular risk hormone","volume":"54","author":"Yoshimoto","year":"2007","journal-title":"Endocrine Journal"},{"issue":"1","key":"10.1016\/bs.apcsb.2024.10.001_bib320","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.rdc.2015.08.004","article-title":"Infection Risk and Safety of Corticosteroid Use","volume":"42","author":"Youssef","year":"2016","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib321","article-title":"Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR\/GPX4 axis activated ferroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib322","series-title":"Vitamins and hormones","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/bs.vh.2017.04.002","article-title":"Chapter three\u2014Nuclear import and export of the thyroid hormone receptor","author":"Zhang","year":"2018"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib323","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/aps.2014.109","article-title":"Regulation of the nongenomic actions of retinoid X receptor-\u03b1 by targeting the coregulator-binding sites","volume":"36","author":"Zhang","year":"2015","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib324","doi-asserted-by":"crossref","first-page":"14210","DOI":"10.3390\/ijms160614210","article-title":"Transcriptional factors mediating retinoic acid signals in the control of energy metabolism","volume":"16","author":"Zhang","year":"2015","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib325","first-page":"1207","article-title":"Nuclear receptors: Recent drug discovery for cancer therapies","volume":"40","author":"Zhao","year":"2019","journal-title":"Endocrine Reviews"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib326","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00432-011-1109-7","article-title":"Etoposide, vincristine, doxorubicin and dexamethasone (EVAD) combination chemotherapy as second-line treatment for advanced AIDS-related Kaposi\u2019s sarcoma","volume":"138","author":"Zhong","year":"2012","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"issue":"4","key":"10.1016\/bs.apcsb.2024.10.001_bib327","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ijc.34512","article-title":"Proxalutamide in metastatic castration\u2010resistant prostate cancer: Primary analysis of a multicenter, randomized, open\u2010label, phase 2 trial","volume":"153","author":"Zhou","year":"2023","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.apcsb.2024.10.001_bib328","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1089\/thy.2019.0007","article-title":"A liver-specific thyromimetic, VK2809, decreases hepatosteatosis in glycogen storage disease type Ia","volume":"29","author":"Zhou","year":"2019","journal-title":"Thyroid: Official Journal of the American Thyroid Association"},{"key":"10.1016\/bs.apcsb.2024.10.001_fur1","doi-asserted-by":"crossref","first-page":"7606","DOI":"10.1002\/anie.201601116","article-title":"Chemistry and biology in the biosynthesis and action of thyroid hormones","volume":"55","author":"Mondal","year":"2016","journal-title":"Angewandte Chemie (International Ed. in English)"},{"key":"10.1016\/bs.apcsb.2024.10.001_fur2","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jmb.2006.05.008","article-title":"Structural rearrangements in the thyroid hormone receptor hinge domain and their putative role in the receptor function","volume":"360","author":"Nascimento","year":"2006","journal-title":"Journal of Molecular Biology"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Nuclear Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162324001020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876162324001020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T11:58:46Z","timestamp":1750852726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876162324001020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443295645"],"references-count":330,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2024.10.001","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}